Neptune Technologies & Bioresources Inc
(NASDAQ:NEPT)|
0.44 +0.08 (22.22%) 1:51ET Delayed |
|
|
|
- Compare NEPT with:
- View: Line | Candlestick
Company Profile
Neptune Technologies & Bioresources Inc
225 Promenade du Centropolis
Laval, Quebec, H7T 0B3
Canada - Map
Phone: (450) 687-2262
Fax: (450) 687-2272
Website: www.neptunebiotech.com
CEO: Henri Harland
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Dvlp high value added nutritional products
A biotechnology company that researches and develops novel extraction technologies, potent biological therapeutics agents and intellectual property for prevalent chronic conditions still lacking safe and definitive treatment solutions.
Recent news for NEPT
-
Update on Neptune Technologies Notes
CNW Group - Nov 27 at 1:46 ET
-
Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
PR Newswire - Nov 19 at 9:57 ET
-
Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
PR Newswire - Oct 21 at 8:37 ET
-
Neptune Technologies & Bioressources Inc. reports first quarter results
PR Newswire - Oct 10 at 5:03 ET
-
PR Newswire - Oct 09 at 5:00 ET
-
PR Newswire - Sep 25 at 2:00 ET
-
PR Newswire - Sep 15 at 5:00 ET
-
Neptune Technologies decided not to re-price options
PR Newswire - Sep 12 at 5:00 ET
-
Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
PR Newswire - Sep 08 at 5:00 ET
-
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Financials
EDGAR Online Financials - Sep 03 at 8:04 ET